Recent research highlight that BCAAs enhance glycolysis and OXPHOS in CD8+ T cells, leading to improved tumor infiltration and immune effector capacity [411], which could be poised to become a significant future research direction for the metabolic reprogramming of NK cells in TME. Here, CD8A is linked to neoplasm.